Log in
ASX:GSS

Genetic Signatures Limited (GSS.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in North America and Australia. The company designs and manufactures a suite of real-time polymerase chain reaction based products for detection of infectious diseases under EasyScreen brand name. It also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. Genetic Signatures Limited was founded in 2001 and is headquartered in Sydney, Australia.

MarketRank

Overall MarketRank

0.33 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 2 9870 7580
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$13.90 million
Book ValueA$0.32 per share

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableOptionable

Receive GSS News and Ratings via Email

Sign-up to receive the latest news and ratings for GSS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Genetic Signatures Limited (GSS.AX) (ASX:GSS) Frequently Asked Questions

What stocks does MarketBeat like better than Genetic Signatures Limited (GSS.AX)?

Wall Street analysts have given Genetic Signatures Limited (GSS.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Genetic Signatures Limited (GSS.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Genetic Signatures Limited (GSS.AX)'s key competitors?

Who are Genetic Signatures Limited (GSS.AX)'s key executives?

Genetic Signatures Limited (GSS.AX)'s management team includes the following people:
  • Dr. John R. Melki, MD, CEO & Exec. Director
  • Mr. Peter Manley, CFO & Company Sec.
  • Mr. Michael Anton Aicher M.B.A., BSc, MBA, Exec. Director of US Operations & Exec. Director (Age 61, Pay $178.1k)
  • Mr. Christopher M. Abbott, Founder & Chairman Emeritus
  • Dr. Douglas S. Millar BSc, Ph.D., Chief Scientific Officer
  • Mr. Jackson Jones, Director of Global Sales & Marketing
  • Mr. Patrick Noland BSc, MBA, US Market Consultant

What is Genetic Signatures Limited (GSS.AX)'s stock symbol?

Genetic Signatures Limited (GSS.AX) trades on the ASX under the ticker symbol "GSS."

How big of a company is Genetic Signatures Limited (GSS.AX)?

Genetic Signatures Limited (GSS.AX) has a market capitalization of $0.00 and generates $13.90 million in revenue each year.

What is Genetic Signatures Limited (GSS.AX)'s official website?

The official website for Genetic Signatures Limited (GSS.AX) is www.geneticsignatures.com.

How can I contact Genetic Signatures Limited (GSS.AX)?

The company can be reached via phone at 61 2 9870 7580.

This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.